Dynavax Technologies

Sanofi to Buy Dynavax for $2.2 Billion in All-Cash Tender Offer

The cash offer seeks to expand Sanofi’s adult immunization portfolio via a two-dose hepatitis B vaccine alongside an early shingles candidate.